These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 56053)

  • 1. Synthesis of heparin-sepharoses and their binding with thrombin and antithrombin-heparin cofactor.
    Danishefsky I; Tzeng F; Ahrens M; Klein S
    Thromb Res; 1976 Feb; 8(2):131-40. PubMed ID: 56053
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of different ions on the interactions of heparin with bovine antithrombin III and thrombin.
    Oshima G; Nagasawa K
    Thromb Res; 1986 May; 42(3):375-82. PubMed ID: 3715809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A catalytic role for heparin. Evidence for a ternary complex of heparin cofactor thrombin and heparin.
    Pomerantz MW; Owen WG
    Biochim Biophys Acta; 1978 Jul; 535(1):66-77. PubMed ID: 78728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of three types of heparin-sepharose and their binding activities to thrombin and antithrombin III.
    Funahashi M; Matsumoto I; Seno N
    Anal Biochem; 1982 Nov; 126(2):414-21. PubMed ID: 7158775
    [No Abstract]   [Full Text] [Related]  

  • 5. Chromatography of heparin on sepharose-lysine: molecular size fractionation and its relevance to thrombin and antithrombin III binding.
    Hatton MW; Berry LR; Kaur H; Koj A; Regoeczi E
    Can J Biochem; 1979 Oct; 57(10):1183-90. PubMed ID: 120212
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for an ester bond between thrombin and heparin cofactor.
    Owen WG; Penick GD; Yoder E; Poole BL
    Thromb Haemost; 1976 Feb; 35(1):87-95. PubMed ID: 60792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.
    Collen D; Schetz J; de Cock F; Holmer E; Verstraete M
    Eur J Clin Invest; 1977 Feb; 7(1):27-35. PubMed ID: 65284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of anticoagulant mechanism of low molecular weight heparin.
    Hamano S; Nishiyama M; Komatsu H; Miyata H; Ikeda S; Sakuragawa N
    Thromb Res; 1992 Mar; 65(6):801-8. PubMed ID: 1321995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin cofactor and antithrombin.
    Abildgaard U
    Thromb Diath Haemorrh; 1975 Feb; 33(1):38-42. PubMed ID: 47193
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
    Tripodi A; Krachmalnicoff A; Mannucci PM
    Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin.
    Austin RC; Sheffield WP; Rachubinski RA; Blajchman MA
    Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):345-51. PubMed ID: 1546950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.
    Einarsson R; Andersson LO
    Biochim Biophys Acta; 1977 Jan; 490(1):104-11. PubMed ID: 65182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for semi micro or automated determination of thrombin, antithrombin, and heparin cofactor using he substrate, H-D-Phe-Pip-Arg-p-nitroanilide-2HCl.
    Scully MF; Kakkar VV
    Clin Chim Acta; 1977 Sep; 79(3):595-602. PubMed ID: 70286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the molecular mass dependency of heparin stimulation of heparin cofactor II:thrombin interaction to antithrombin III:thrombin interaction.
    Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1987 May; 46(3):491-502. PubMed ID: 3603437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of heparin on thrombin-antithrombin reaction.
    Machovich R; Blaskó G; Pálos LA
    Biochim Biophys Acta; 1975 Jan; 379(1):193-200. PubMed ID: 1115795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple two-step isolation procedure for human and bovine antithrombin II/III (heparin cofactor): a comparison of two methods.
    Thaler E; Schmer G
    Br J Haematol; 1975 Oct; 31(2):233-43. PubMed ID: 53066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-like tubings. III. Kinetics and mechanism of thrombin, antithrombin III and thrombin-antithrombin complex adsorption under controlled-flow conditions.
    Migonney V; Fougnot C; Jozefowicz M
    Biomaterials; 1988 Sep; 9(5):413-8. PubMed ID: 3224126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation on interaction of fractionated 3H-heparin with plasma proteins by gel filtration chromatography.
    Watanabe J; Nakagaki H; Yuasa H; Ozeki S
    J Pharmacobiodyn; 1989 Jul; 12(7):416-22. PubMed ID: 2480440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin.
    Lane DA; Flynn A; Ireland H; Erdjument H; Samson D; Howarth D; Thompson E
    Br J Haematol; 1987 Apr; 65(4):451-6. PubMed ID: 3580302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.